Cost-reduction analysis for oral versus intravenous fludarabine (Beneflur®) in Spain
Análisis de minimización de costes de fludarabina (Beneflur®) oral vs. vía intravenosa en España
Leído
3029
Vecesse ha leído el artículo
1363
Total PDF
1666
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 48 | 14 | 62 |
| 2025 10 | 84 | 51 | 135 |
| 2025 9 | 48 | 31 | 79 |
| 2025 8 | 34 | 28 | 62 |
| 2025 7 | 47 | 32 | 79 |
| 2025 6 | 51 | 17 | 68 |
| 2025 5 | 67 | 18 | 85 |
| 2025 4 | 62 | 28 | 90 |
| 2025 3 | 53 | 27 | 80 |
| 2025 2 | 40 | 17 | 57 |
| 2025 1 | 50 | 28 | 78 |
| 2024 12 | 45 | 18 | 63 |
| 2024 11 | 40 | 29 | 69 |
| 2024 10 | 37 | 18 | 55 |
| 2024 9 | 52 | 26 | 78 |
| 2024 8 | 38 | 27 | 65 |
| 2024 7 | 23 | 22 | 45 |
| 2024 6 | 37 | 25 | 62 |
| 2024 5 | 32 | 19 | 51 |
| 2024 4 | 38 | 25 | 63 |
| 2024 3 | 27 | 19 | 46 |
| 2024 2 | 35 | 20 | 55 |
| 2024 1 | 16 | 26 | 42 |
| 2023 12 | 25 | 27 | 52 |
| 2023 11 | 45 | 26 | 71 |
| 2023 10 | 27 | 21 | 48 |
| 2023 9 | 37 | 26 | 63 |
| 2023 8 | 11 | 14 | 25 |
| 2023 7 | 18 | 18 | 36 |
| 2023 6 | 12 | 20 | 32 |
| 2023 5 | 14 | 29 | 43 |
| 2023 4 | 11 | 27 | 38 |
| 2023 3 | 13 | 21 | 34 |
| 2023 2 | 8 | 11 | 19 |
| 2022 1 | 9 | 6 | 15 |
| 2022 12 | 12 | 5 | 17 |
| 2022 11 | 7 | 4 | 11 |
| 2022 10 | 11 | 11 | 22 |
| 2022 9 | 7 | 12 | 19 |
| 2022 8 | 15 | 10 | 25 |
| 2022 7 | 8 | 7 | 15 |
| 2022 6 | 15 | 13 | 28 |
| 2022 5 | 13 | 2 | 15 |
| 2022 4 | 20 | 4 | 24 |
| 2022 3 | 9 | 6 | 15 |
| 2022 2 | 9 | 7 | 16 |
| 2021 1 | 4 | 9 | 13 |
| 2021 12 | 4 | 17 | 21 |
| 2021 11 | 7 | 6 | 13 |
| 2021 10 | 7 | 11 | 18 |
| 2021 9 | 6 | 8 | 14 |
| 2021 8 | 9 | 3 | 12 |
| 2021 7 | 2 | 10 | 12 |
| 2021 6 | 5 | 11 | 16 |
| 2021 5 | 4 | 8 | 12 |
| 2021 4 | 9 | 12 | 21 |
| 2021 3 | 3 | 5 | 8 |
| 2021 2 | 2 | 5 | 7 |
| 2020 1 | 7 | 14 | 21 |
| 2020 12 | 6 | 9 | 15 |
| 2020 11 | 6 | 7 | 13 |
| 2020 10 | 4 | 5 | 9 |
| 2020 9 | 7 | 4 | 11 |
| 2020 8 | 4 | 5 | 9 |
| 2020 7 | 5 | 3 | 8 |
| 2020 6 | 4 | 2 | 6 |
| 2020 5 | 1 | 7 | 8 |
| 2020 4 | 3 | 6 | 9 |
| 2020 3 | 6 | 4 | 10 |
| 2020 2 | 3 | 6 | 9 |
| 2020 1 | 5 | 14 | 19 |
| 2019 12 | 2 | 12 | 14 |
| 2019 11 | 4 | 4 | 8 |
| 2019 10 | 1 | 8 | 9 |
| 2019 9 | 3 | 12 | 15 |
| 2019 8 | 1 | 6 | 7 |
| 2019 7 | 2 | 16 | 18 |
| 2019 6 | 13 | 36 | 49 |
| 2019 5 | 28 | 77 | 105 |
| 2019 4 | 6 | 28 | 34 |
| 2019 3 | 2 | 8 | 10 |
| 2019 2 | 1 | 4 | 5 |
| 2019 1 | 0 | 8 | 8 |
| 2018 12 | 2 | 3 | 5 |
| 2018 11 | 0 | 1 | 1 |
| 2018 10 | 4 | 10 | 14 |
| 2018 9 | 4 | 0 | 4 |
| 2018 8 | 2 | 0 | 2 |
| 2018 7 | 1 | 2 | 3 |
| 2018 6 | 1 | 3 | 4 |
| 2018 5 | 1 | 4 | 5 |
| 2018 4 | 1 | 2 | 3 |
| 2018 3 | 3 | 0 | 3 |
| 2018 1 | 0 | 1 | 1 |
| 2017 12 | 2 | 1 | 3 |
| 2017 11 | 1 | 1 | 2 |
| 2017 10 | 7 | 1 | 8 |
| 2017 9 | 4 | 6 | 10 |
| 2017 8 | 6 | 1 | 7 |
| 2017 7 | 6 | 1 | 7 |
| 2017 6 | 8 | 2 | 10 |
| 2017 5 | 11 | 1 | 12 |
| 2017 4 | 7 | 1 | 8 |
| 2017 3 | 8 | 17 | 25 |
| 2017 2 | 6 | 2 | 8 |
| 2016 1 | 7 | 0 | 7 |
| 2016 12 | 6 | 0 | 6 |
| 2016 11 | 14 | 0 | 14 |
| 2016 10 | 5 | 1 | 6 |
| 2016 9 | 2 | 0 | 2 |
| 2016 8 | 1 | 0 | 1 |
Mostrar todo
